Document:

Exhibit 10.7

NEITHER THIS WARRANT NOR THE SHARES OF STOCK ISSUABLE UPON EXERCISE HEREOF HAVE
BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "ACT"). NO
SALE, TRANSFER OR OTHER DISPOSITION OF THIS WARRANT OR SAID SHARES MAY BE
EFFECTED WITHOUT (A) (i) AN EFFECTIVE REGISTRATION STATEMENT RELATED THERETO OR
(ii) AN OPINION OF COUNSEL FOR THE HOLDER, REASONABLY SATISFACTORY TO THE
COMPANY, THAT SUCH REGISTRATION IS NOT REQUIRED AND (B) COMPLIANCE WITH
RESTRICTIONS ON TRANSFER SET FORTH IN SECTION 7 OF THIS WARRANT.

                                 WARRANT NO. MW-

                                    AVP, INC.

                          COMMON STOCK PURCHASE WARRANT

      THIS CERTIFIES THAT, for good and valuable consideration received,
__________ ("Holder"), is entitled to purchase from AVP, Inc., a Delaware
corporation with its principal place of business at 6100 Center Drive, Suite
900, Los Angeles CA 90045 (the "Company") ________ shares (as adjusted pursuant
to provisions hereof, the "Shares") of the Company's fully paid and
non-assessable Common Stock, at an exercise price per share of $2.20 (such price
and such other price as shall result, from time to time, from adjustments
specified herein, is hereafter referred to as the "Exercise Price"), subject to
the provisions and upon the terms and conditions hereinafter set forth. As used
herein, the term "Grant Date" shall mean June 24, 2005.

      1. Term. This Warrant is exercisable, in whole or in part, at any time and
from time to time, from and after the Grant Date until the close of business,
Los Angeles time, on the date immediately preceding the fourth anniversary of
the Grant Date (the "Expiration Date").

      2. Method of Exercise. The Holder may exercise this Warrant, in whole or
in part and from time to time, by the surrender of this Warrant (with the notice
of exercise form attached hereto as Annex A duly executed) at the principal
office of the Company and by the payment to the Company of an amount equal to
the then applicable Exercise Price per share multiplied by the number of Shares
for which the Warrant is then being exercised. The Holder shall be deemed to
have become the holder of record of, and shall be treated for all purposes as
the record holder of, the Shares purchased on exercise hereof (and such Shares
shall be deemed to have been issued) immediately prior to the close of business
on each date that this Warrant is exercised. Upon any exercise of this Warrant,
Company shall deliver certificates for the Shares so purchased promptly, and,
unless this Warrant has been fully exercised or expired, a new Warrant
representing the portion of the Shares, if any, with respect to which this
Warrant shall not then have been exercised.

      3. Stock Fully Paid; Reservation of Shares. All Shares issuable upon the
exercise of this Warrant (the "Warrant Shares"), upon issuance, will be validly
issued, fully paid and non-assessable. During the term of this Warrant, the
Company shall keep a sufficient number of shares of Common Stock authorized and
reserved for issuance upon exercise of this Warrant.

<PAGE>

      4. Adjustment of Exercise Price and Number of Shares. The number of Shares
subject to this Warrant and the Exercise Price may be adjustment from time to
time, as follows:

            (a) Reclassification, Reorganization, Merger or Sale. In case of any
(i) reclassification, reorganization or recapitalization (other than a change in
par value, or from par value to no par value, or from no par value to par value,
or as a result of a subdivision or combination), or (ii) consolidation or merger
of the Company with or into another corporation or entity (other than a merger
with another corporation or entity in which the Company is the surviving
corporation and that does not result in any reclassification or change of
outstanding securities issuable upon exercise of this Warrant), or (iii) sale of
all or substantially all of the Company's assets (collectively, "Adjustment
Transactions"), the Company shall make provision (reasonably satisfactory to the
Holder), or such successor or purchasing corporation, so that the holder of this
Warrant shall have the right thereafter to receive upon the exercise hereof the
kind and amount of Shares or other securities or property that such holder would
have been entitled to receive, if, immediately prior to any such Adjustment
Transaction, the Holder had held the number of Warrant Shares that at such time
could have been purchased upon full exercise of this Warrant. In any such case,
appropriate adjustments (as reasonably determined in good faith by the Company's
Board of Directors) of this Warrant shall be made such that the provisions set
forth in this Section 4 (including provisions with respect to adjustment of the
Exercise Price) shall thereafter be applicable, as nearly as is practicable, in
relation to any shares of stock or other securities or property thereafter
deliverable upon the exercise of this Warrant. The provisions of this Section
4(a) shall similarly apply to successive reclassifications, changes,
consolidations, mergers and sales. The Company shall not effect or agree to
effect any Adjustment Transaction unless, prior to the consummation thereof, the
surviving successor person (if other than the Company) of such Adjustment
Transaction, shall by written instrument, confirm its obligation to deliver such
shares of stock, securities or assets, to which, in accordance with the
foregoing provisions, the Holder shall be entitled to receive upon exercise
hereof.

            (b) Subdivisions or Combination of Shares; Stock Dividends. If the
Company shall at any time subdivide the outstanding Common Stock into a greater
number of shares, or issue a stock dividend on the outstanding Common Stock the
number of Shares immediately prior to such subdivision or at the record date of
such stock dividend shall, simultaneously with the effectiveness of such
subdivision or immediately after the record date of such dividend, be
proportionately increased, and the Exercise Price then in effect shall be
proportionately decreased. If the Company shall at any time combine the
outstanding Common Stock into a smaller number of shares, the number of Shares
immediately prior to such combination shall, simultaneously with the
effectiveness of such combination, be proportionately decreased, and the
Exercise Price then in effect shall be proportionately increased, effective on
the date of such combination.

            (c) No Impairment. The Company will not, by amendment of its
Certificate of Incorporation or through any reorganization, recapitalization,
transfer of assets, consolidation, merger, dissolution, issue or sale of
securities, or any other action, seek to avoid the Company's obligations
hereunder, but will at all times in good faith assist in the effectuation of all
provisions of this Section 4 and in the taking of all such action as may be
necessary or appropriate to preserve the Holder's rights hereunder.

                                       2
<PAGE>

      5. Notice of Adjustments. Whenever the Exercise Price shall be adjusted
pursuant to the provisions hereof, the Company shall within 30 days after such
adjustment deliver a certificate signed on behalf of the Company by its chief
financial officer to the Holder setting forth, in reasonable detail, the event
requiring the adjustment, the amount of the adjustment, the method by which such
adjustment was calculated, and the Exercise Price after giving effect to such
adjustment. Such certificate shall also set forth the kind and amount of stock
or other securities or property into which this Warrant shall be exercisable
following the occurrence of any of the events specified in Section 4(a) or (b).

      6. Fractional Shares. In lieu of any fractional Share otherwise issuable
pursuant hereto, the Company shall make a cash payment equal to the product
obtained by multiplying such fraction by the Exercise Price then in effect.

      7. Compliance with Securities Act; Disposition of Warrant or Shares of
Common Stock.

            (a) Compliance with Securities Act. The holder of this Warrant, by
acceptance hereof, agrees that this Warrant and the Warrant Shares are being
acquired for investment purposes only and that such holder will not offer, sell
or otherwise dispose of this Warrant or any Warrant Shares except under
circumstances that will not result in a violation of the Act and as permitted by
Section 7(b) and Section 7(c) below. This Warrant and all Warrant Shares (unless
registered under the Act) shall be stamped or imprinted with a legend (the
"Securities Legend") in substantially the following form:

            THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN
            REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "ACT").
            NO SALE OR OTHER DISPOSITION MAY BE EFFECTED WITHOUT (i) AN
            EFFECTIVE REGISTRATION STATEMENT RELATED THERETO OR (ii) AN OPINION
            OF COUNSEL FOR THE HOLDER, REASONABLY SATISFACTORY TO THE COMPANY,
            THAT SUCH REGISTRATION IS NOT REQUIRED.

            (b) Disposition of Warrant and Warrant Shares. With respect to any
sale or other disposition of this Warrant or any Warrant Shares acquired upon
exercise of this Warrant, prior to registration of such shares, the holder
hereof and each subsequent holder of this Warrant agrees to give 10 days'
written notice to the Company prior thereto, describing briefly the manner
thereof, together with a written opinion of such holder's counsel, reasonably
satisfactory to the Company, to the effect that such sale or other disposition
may be effected without registration or qualification (under the Act as then in
effect) of this Warrant or such Warrant Shares stating whether under the Act
this Warrant or the certificate representing the Warrant Shares requires any
restrictive legend thereon in order to ensure compliance with the Act. This
Warrant or the certificates representing the Warrant Shares thus transferred
shall bear the Securities Legend as to the applicable restrictions on
transferability in order to ensure compliance with the Act, unless in the
aforesaid opinion of counsel for the holder, such Securities Legend is not
required in order to insure compliance with the Act. If the Securities Legend is
not required, Company agrees to reissue the Warrant and/or the Warrant Shares
without said Securities Legend. Nothing herein shall restrict the transfer of
this Warrant (or any portion hereof) or the certificates representing the
Warrant Shares by the initial holder hereof or any successor holder to (i) any
affiliate of such holder, including without limitation any partnership
affiliated with such holder, any partner of any such partnership or any
successor corporation to the holder hereof as a result of a merger or
consolidation with or a sale of all or substantially all of the stock or assets
of the holder, if such affiliate or partner agrees in writing to be bound by all
of the restrictions on transfer contained herein, (ii) any legal entity or
natural person (hereinafter "Person") in a public offering pursuant to an
effective registration statement under the Act or (iii) to any other Person to
the extent that the transfer to such Person is exempt from the registration
requirements of the Act and such Person agrees in writing to be bound by all of
the restrictions on transfer contained herein, and such Person agrees in writing
to be bound by all of the restrictions on transfer contained herein. Any
transfer described above must be made in compliance with all applicable federal
and state securities laws. The Company may issue stop transfer instructions to
its transfer agent in connection with the foregoing restrictions.

                                       3
<PAGE>

      8. Rights as Stockholders. No holder of this Warrant, as such, shall be
entitled to vote or receive dividends or be deemed the holder of Warrant Shares
or otherwise be entitled to any voting or other rights as a stockholder of the
Company, until this Warrant shall have been exercised and the shares purchasable
upon the exercise shall have become deliverable, as provided herein.

      9. Issuance Tax. The issuance of certificates for Warrant Shares shall be
made without charge to the holder hereof for any issuance tax in respect hereof,
provided that the Company shall not be required to pay any income tax or tax
which may be payable in respect of any transfer involved in the issuance and
delivery of any certificate in a name other than that of the holder of this
Warrant.

      10. Transfers, etc.

            (a) The Company will maintain a register containing the names and
addresses of the Holder. The Holder may change its address as shown on the
warrant register by written notice to the Company requesting such change.

            (b) Subject to the provisions of Section 7, this Warrant and all
rights hereunder are transferable, in whole or in part, upon surrender of this
Warrant with a properly executed assignment (in the form of Annex B hereto) at
the principal office of the Company.

            (c) Until any transfer of this Warrant is made in the warrant
register, the Company may treat the Holder as the absolute owner hereof for all
purposes; provided, however, that if and when this Warrant is properly assigned
in blank, the Company may (but shall not be obligated to) treat the bearer
hereof as the absolute owner hereof for all purposes, notwithstanding any notice
to the contrary.

      11. Modification and Waiver. This Warrant and any provision hereof may be
changed, waived, discharged, or terminated only by an instrument in writing
signed by the Company and the holder of this Warrant.

      12. Notices. Any notice, request or other document required or permitted
to be given or delivered to the holder hereof or the Company shall be delivered,
or shall be sent by certified or registered mail, postage prepaid, to such
holder at its address as shown on the books of the Company or to the Company at
the address indicated therefore on the signature page of this Warrant.

                                       4
<PAGE>

      13. Binding Effect on Successors. This Warrant shall be binding upon any
corporation succeeding the Company by merger, consolidation or acquisition of
all or substantially all of the Company's assets, and all of the obligations of
the Company relating to Warrant Shares shall survive the exercise and
termination of this Warrant, and all of the covenants and agreements of the
Company shall inure to the benefit of the successors and assigns of the holder
hereof, except as otherwise set forth herein. The Company will, at the time of
the exercise of this Warrant, in whole or in part, upon request of the holder
hereof but at the Company's expense, acknowledge in writing its continuing
obligation to the holder hereof in respect of any rights (including, without
limitation, any right to registration of the Shares) to which the holder hereof
shall continue to be entitled after such exercise in accordance with this
Warrant; provided that the failure of the holder hereof to make any such request
shall not affect the continuing obligation of the Company to the holder hereof
in respect of such rights.

      14. Lost Warrants or Stock Certificates. The Company covenants to the
Holder that, upon receipt of evidence reasonably satisfactory to the Company of
the loss, theft, destruction, or mutilation of this Warrant or any stock
certificate issued upon exercise hereof or in replacement thereafter, and, in
the case of any such loss, theft or destruction, upon receipt of an indemnity
reasonably satisfactory to the Company and without requiring any bond, or in the
case of any such mutilation upon surrender and cancellation of such Warrant or
stock certificate, the Company will make and deliver a new Warrant or stock
certificate, or like tenor, in lieu of the lost, stolen, destroyed or mutilated
Warrant or stock certificate.

      15. Descriptive Headings. The descriptive headings of the several
paragraphs of this Warrant are inserted for convenience only and do not
constitute a part of this Warrant.

      16. Registration Rights. The Holder shall have the piggy-back registration
rights referred to in Schedule 1.

      17. Governing Law. WITH RESPECT TO ALL ISSUES CONCERNING THE RELATIVE
RIGHTS OF THE COMPANY AND ITS STOCKHOLDERS, THIS WARRANT SHALL BE CONSTRUED AND
ENFORCED IN ACCORDANCE WITH, AND THE RIGHTS OF THE PARTIES SHALL BE GOVERNED BY,
THE LAWS OF THE STATE OF THE COMPANY'S INCORPORATION. FOR ALL OTHER ISSUES AND
QUESTIONS, THIS WARRANT SHALL BE CONSTRUED AND ENFORCED IN ACCORDANCE WITH, AND
THE RIGHTS OF THE PARTIES SHALL BE GOVERNED BY, THE LAWS OF THE STATE OF
CALIFORNIA.

                         [SIGNATURE BLOCK ON NEXT PAGE]

                                       5
<PAGE>

      IN WITNESS WHEREOF, AVP, INC. has caused this Warrant to be executed on
January 12, 2006, effective as of the date below, by its officers thereunto duly
authorized.

                                    AVP, INC.

                                    By:  _____________________________________

Dated: June 24, 2005

                                       6
<PAGE>

                                   Schedule 1

                         REGISTRATION OF WARRANT SHARES

            The Company shall register Warrant Shares issued to the original
Holder according to the following: At any time after February 28, 2006 until the
fifth year after the Grant Date that the Company proposes to file under the
Securities Act a re-sale registration statement pursuant to Securities Act Rule
415(a)(1),(iii), or (iv), only (except with respect to registration statements
on Forms S-4 or S-8 or another form not generally available for registration of
securities), the Company will give written notice thereof to the original Holder
(if the original Holder has remained such) at least 15 days before filing. Upon
written request of such Holder (which request shall specify the number of
Warrant Shares that such Holder intended to sell), received by the Company
within ten (10) days after the Company's giving any such notice, to register any
of such Holder's Warrant Shares, the Company will use its reasonable efforts to
cause the Warrant Shares as to which registration shall have been so requested
to be included in the securities to be covered by the registration statement
proposed to be filed by the Company.

            The rights and obligations of the Holder with respect to Warrant
Shares that the Company shall be required to register pursuant to the preceding
paragraph shall be the same, mutatis mutandis, as are applicable to security
holders whose securities otherwise are being registered, except that the
Holder's rights shall be junior to those of the other security holders, insofar
as any agreement giving them registration rights prohibits the Holder's having
rights pari passu with or senior to the rights to other security holders
(regardless whether such agreement uses such terminology, or, instead, contains
provisions having such effect). The Company's obligations hereunder shall be
conditioned up the Holder's signing an agreement confirming the same. If none of
such other security holders is a party to any agreement giving registration
rights, the Company's obligations hereunder shall be conditioned up the Holder's
signing an agreement containing terms customarily applicable to the exercise of
piggy-back registration rights.

                                       7
<PAGE>

                                     ANNEX A

                               Notice of Exercise

To:   AVP, Inc. ("Company")
6100 Center Drive
Suite 900
Los Angeles CA  90045
COO

      1. The undersigned hereby elects to purchase __________________________
shares of Company Common Stock pursuant to the terms of the attached Warrant,
and tenders herewith payment of the Exercise Price of such shares in full.

      2. Please issue a certificate or certificates representing said shares in
the name of the undersigned or in such other name or names as are specified
below:

      ---------------------

      ---------------------

      3. In exercising this warrant, the undersigned hereby represents and
warrants that the aforesaid shares are being acquired for the account of the
undersigned for investment and not with a view to, or for resale in connection
with, the distribution thereof and acknowledges that the certificate
representing the shares shall bear a Securities Act transfer restriction.

                                    -----------------------------------------

                                    By:
                                       --------------------------------------
                                    Its:
                                        -------------------------------------

                                    Date:
                                         ------------------------------------

                                       8
<PAGE>

                                     ANNEX B

                                 ASSIGNMENT FORM

            FOR VALUE RECEIVED, _______________________________ hereby sells,
assigns and transfers all of the rights of the undersigned under the attached
Warrant unto:

     Name of Assignee                Address             No. of Warrant Shares
     ----------------                -------             ---------------------

Dated:
      ------------------
By:
   ---------------------

                                       9Date__________

Molecular Diagnostics, Inc.
414 North Orleans Street
Suite 502
Chicago, Illinois 60610

Ladies and Gentlemen:

      This  Subscription  Agreement (the  "AGREEMENT") sets forth the agreements
and  understandings   between  the  undersigned   ("SUBSCRIBER")  and  Molecular
Diagnostics,  Inc.,  a  corporation  organized  under the laws of Delaware  (the
"COMPANY"),  relating to  Subscriber's  subscription  for,  and purchase of, the
number of  shares  of common  stock,  par  value  $.001 per share  (the  "COMMON
Stock"), of the Company set forth on the signature page hereto (the "SHARES").

      1.   CONDITIONS  TO  SUBSCRIPTION   ACCEPTANCE  AND  CLOSING.   Subscriber
understands  and  agrees  that  this   subscription   and  the  closing  of  the
transactions  contemplated  hereby  (the  "CLOSING")  is  made  subject  to  the
following terms and conditions:

            (a) The Company has the right to accept or reject this  subscription
in whole or in part.  Unless  this  subscription  is  rejected by the Company by
__________  (which date may be extended to __________ by the Company in its sole
discretion without notice to or approval by Subscriber), this subscription shall
be deemed accepted in whole.

            (b) On or prior to the date of the  Closing,  Subscriber  shall have
furnished  the  Company  with  such  information,  documents,  certificates  and
opinions  as the  Company  may  reasonably  require to  evidence  the  accuracy,
completeness  or  satisfaction of the  representations,  warranties,  covenants,
agreements  and  conditions  herein  contained or as the Company  otherwise  may
reasonably require.

      2.  SUBSCRIBER   REPRESENTATIONS   AND  WARRANTIES.   In  connection  with
Subscriber's   subscription  for,  and  purchase  of,  the  Shares,   Subscriber
represents and warrants to the Company that:

            (a) If Subscriber is a natural person, Subscriber (i) is a bona fide
resident of the state or  jurisdiction  set forth on the signature  page of this
Agreement as Subscriber's home address, and has no present intention of becoming
a resident of any other state or jurisdiction; (ii) is at least 21 years of age;
and (iii) is legally competent to execute this Agreement and any other documents
and  instruments  required  in  connection  herewith,  if any (the  "TRANSACTION
DOCUMENTS").  If Subscriber is an entity,  the person signing this Agreement and
the Transaction  Documents on behalf of the entity is duly authorized to execute
and  deliver  this  Agreement  and  the  Transaction   Documents  on  behalf  of
Subscriber.  This Agreement and the Transaction  Documents constitute the legal,
valid and binding  obligations  of Subscriber,  enforceable  in accordance  with
their  terms,  except  as  such  enforceability  may be  limited  by  applicable
bankruptcy,  insolvency or similar laws  relating to or affecting  generally the
enforcement of creditors' rights and remedies or by other equitable principles.

<PAGE>

            (b) The execution and delivery of this Agreement and the Transaction
Documents  by  Subscriber  do not, and the  performance  of the terms hereof and
thereof will not,  contravene any material law, rule,  regulation,  order, writ,
judgment,  injunction,  decree, determination or award applicable to Subscriber,
or of the charter, bylaws,  operating agreement,  partnership agreement or other
governing agreements of Subscriber (if applicable),  and will not conflict with,
or  result  in any  breach  of,  the  terms,  conditions  or  provisions  of, or
constitute  a default  under,  or give to  others  any  rights  of  termination,
amendment,  acceleration or cancellation of, or result in or permit the creation
or  imposition  of any lien,  charge or  encumbrance  upon any of the  assets of
Subscriber pursuant to any indenture,  mortgage or other agreement or instrument
or any judgment,  decree, order or decision to which Subscriber is a party or by
which Subscriber is bound.

            (c) Under existing law, no approval, authorization,  license, permit
or other  action  by or  filing  with any  Federal,  state,  municipal  or other
governmental  commission,  board or agency is required on the part of Subscriber
in connection with the execution and delivery by Subscriber of this Agreement or
the Transaction Documents, or the consummation of the transactions  contemplated
hereby or thereby.

            (d) There are no actions, suits or proceedings existing, pending or,
to the  knowledge of  Subscriber,  threatened  against or  affecting  Subscriber
before any court,  arbitrator or governmental or  administrative  body or agency
that would  affect the  validity  or  enforceability  of this  Agreement  or the
Transaction  Documents,  or that  would have a  material  adverse  affect on the
ability  of  Subscriber  to  perform  Subscriber's   obligations  hereunder  and
thereunder.

            (e)  Subscriber  has such  knowledge and experience in financial and
business  matters so as to be capable of evaluating and  understanding,  and has
evaluated and  understood,  the merits and risks of an investment in the Company
and the purchase of the Shares,  and Subscriber  has been given the  opportunity
(i) to obtain  information and to examine all documents  relating to the Company
and the Company's  business,  (ii) to ask  questions of, and to receive  answers
from, the Company  concerning the Company,  the Company's business and the terms
and  conditions  of  this  investment,   and  (iii)  to  obtain  any  additional
information,  to the extent the  Company  possesses  such  information  or could
acquire such information without  unreasonable  effort or expense,  necessary to
verify the accuracy of any information previously furnished.  All such questions
have been answered to Subscriber's  full  satisfaction,  and all information and
documents,  records and books pertaining to this investment which Subscriber has
requested have been made available to Subscriber.

            (f)  Subscriber is able to bear the  substantial  economic  risks of
Subscriber's  investment  in the Company and the purchase of the Shares in that,
among other factors,  Subscriber can afford to hold the Shares for an indefinite
period and can afford a complete loss of Subscriber's investment in the Company.

                                       2
<PAGE>

            (g) No material adverse change in Subscriber's  financial  condition
has taken place during the past twelve (12)  months,  and  Subscriber  will have
sufficient  liquidity  with  respect to  Subscriber's  net worth for an adequate
period of time to provide for Subscriber's needs and contingencies.

            (h) Subscriber is relying solely on Subscriber's own decision and/or
the advice of  Subscriber's  own adviser(s) with respect to an investment in the
Company and the purchase of the Shares,  and has neither  received nor relied on
any  communication  from the  Company or its  officers or agents  regarding  any
legal, investment or tax advice relating to an investment in the Company.

            (i)  Subscriber  has had an  opportunity  to read and understand the
provisions of this  Agreement  and the  Transaction  Documents,  to consult with
Subscriber's  adviser(s) or counsel  regarding the operation and consequences of
those  provisions,  and  has  considered  the  effect  of  those  provisions  on
Subscriber.

            (j) Subscriber recognizes that an investment in the Company involves
substantial risks in that, among other factors:  (i) successful operation of the
Company  depends on factors  beyond the control of the Company,  and the Company
has not had profitable operations from its inception to date; (ii) investment in
the Company is a  speculative  investment  and involves a high degree of risk of
loss;  (iii) the Company is engaged in an industry  which is highly  competitive
and subject to substantial  risks; (iv) the Company has a very limited amount of
working capital  available to it; and (v) the Shares may not be registered under
applicable  federal and state  securities laws and,  accordingly,  it may not be
possible to liquidate an investment in the Company in case of immediate  need of
funds or any other  emergency,  if at all.  Subscriber has taken full cognizance
of, and  understands,  such risks and has  obtained  sufficient  information  to
evaluate the merits and risks of an  investment  in the Company and the purchase
of the Shares.

            (k) Subscriber  confirms that none of the Company's officers nor any
of the Company's agents have made any  representations or warranties  concerning
an investment in the Company, including, without limitation, any representations
or warranties  concerning  anticipated  financial results,  or the likelihood of
success of the operations, of the Company.

            (l) Subscriber is acquiring the Shares for Subscriber's own account,
for  investment  and not with a view  to,  or in  connection  with,  any  public
offering or distribution  of the same and without any present  intention to sell
the same at any particular event or circumstance. Subscriber has no agreement or
other  arrangement  with any person to sell,  transfer or pledge any part of the
Shares which would  guarantee  Subscriber any profit or protect against any loss
with respect to the Shares.

                                       3
<PAGE>

            (m)  Subscriber  understands  that  no  U.S.  Federal  or  state  or
international  agency has passed on or made any recommendation or endorsement of
an investment in the Shares.

            (n) Subscriber  understands that the Shares have not been registered
under the  Securities  Act of 1933, as amended (the "ACT"),  or applicable  U.S.
state securities laws or any securities laws of any other jurisdiction,  and are
being  offered and sold under an exemption  from  registration  provided by such
laws and the rules and regulations thereunder.  Further,  Subscriber understands
that the Company is under no obligation to register the Shares or to comply with
any exemption  under any applicable  securities laws with respect thereto or any
other ownership interest in the Company. Subscriber may therefore be required to
bear the economic risks of an investment in the Company for an indefinite period
of time because the Shares cannot be resold unless  registered  under applicable
securities  laws or unless an exemption  from such  registration  is  available.
Subscriber also  understands  that (i) the exemption  provided by Rule 144 under
the Act may not be available  because of the conditions and  limitations of such
rule, and that in the absence of the  availability of such rule, any disposition
by Subscriber of any securities of the Company may require  compliance with some
other  exemption under the Act; and, (ii) the Company is under no obligation and
does not plan to take any action in  furtherance of making Rule 144 or any other
exemption so available.

            (o) If  Subscriber is required in the future to file a Form 144 with
the Securities and Exchange Commission in connection with sales of Shares or any
other  ownership  interest  in the  Company  pursuant to Rule 144 under the Act,
Subscriber  will deliver a copy of such form to the Company at the same time and
each time Subscriber is required to file a copy with the Securities and Exchange
Commission.

            (p) Subscriber is an  "accredited  investor" as such term is defined
in Rule 501(a)  promulgated  under the Act.  Subscriber will execute and deliver
the Confidential  Accredited Investor Questionnaire attached hereto as EXHIBIT A
simultaneously with the execution and delivery of this Agreement.

            (q)  Subscriber  agrees  that  the  foregoing   representations  and
warranties  will  survive the sale of the Shares to  Subscriber,  as well as any
investigation made by any party relying on same.

            (r) Except as Subscriber shall have clearly and expressly  disclosed
to the Company,  Subscriber has not authorized any underwriter,  broker, dealer,
agent or finder to act on  Subscriber's  behalf  (nor does  Subscriber  have any
knowledge  of  any  broker,  dealer,  agent  or  finder  purporting  to  act  on
Subscriber's  behalf)  with respect to  Subscriber's  purchase of the Shares and
Subscriber  has not paid  directly  or  indirectly  any  commission  or  similar
remuneration  with  respect to such  acquisition.  Subscriber  hereby  agrees to
indemnify and hold harmless the Company and its  directors,  officers and agents
from and against any cost, expense, claim, liability or damage arising out of or
resulting from a breach of such representation and warranty.

                                       4
<PAGE>

      3. GENERAL PROVISIONS.

            (a) This  Agreement  will be governed by and construed in accordance
with the  substantive  laws of the  State of  Delaware  without  regard to rules
thereof relating to conflicts of laws.

            (b) This Agreement and the Transaction Documents together constitute
the entire  agreement  between the parties  with  respect to the subject  matter
hereof and thereof and  supersede  any prior  subscription  agreement for Shares
executed by Subscriber. This Agreement may be amended only by a writing executed
by the parties.

            (c) The Shares will be assigned or  transferred  only in  accordance
with  applicable  law  and  the  terms  of this  Agreement  and the  Transaction
Documents.

            (d) This  Agreement will survive  Subscriber's  death or dissolution
and  will  be  binding   upon   Subscriber's   successors,   heirs,   assignees,
representatives and distributees.

                        (Signatures appear on next page.)

      *           *           *           *           *           *

                                       5
<PAGE>

      IN WITNESS  WHEREOF,  Subscriber has hereby  executed this Agreement as of
the date set forth above.

SUBSCRIBER:
-----------

If an Individual:                         If an Entity:

                                          Name of Entity:
                                                         ---------------------

                                          By:
-------------------------------                -------------------------------
[Name]                                    Name:
                                          Title:

Mailing Address:

-------------------------------
-------------------------------
-------------------------------

E-Mail Address:
                  ------------------------------

Social Security Number/U.S. Employer Identification Number:
                                                           -------------------

Number of Shares for which Subscription is tendered:
                                                    ---------------------

Purchase Price per Share:  $0.025
                           -------
Aggregate Consideration:
                          ----------------------------

ACCEPTED:

Molecular Diagnostics, Inc.,
   a Delaware corporation

By:
   ---------------------------------
   Name:
   Title:

Date of Acceptance:
                     ---------------------

                                       6
<PAGE>

                                    EXHIBIT A

                CONFIDENTIAL ACCREDITED INVESTOR QUESTIONNAIRE

      The  undersigned  represents  and warrants that he, she or it comes within
one of the categories marked below, and that for any category marked, he, she or
it has  truthfully set forth the factual basis or reason the  undersigned  comes
within that category.  ALL INFORMATION IN RESPONSE TO THIS QUESTIONNAIRE WILL BE
KEPT STRICTLY  CONFIDENTIAL.  The undersigned  agrees to furnish such additional
information as is reasonably  necessary in order to verify the answers set forth
below.

Please mark next to each applicable paragraph:

      _____ a. The undersigned is an individual (not a partnership, corporation,
            etc.) whose individual net worth, or joint net worth with his or her
            spouse, presently exceeds $1,000,000.

                  EXPLANATION.  In calculating net worth, you may include equity
                  in personal property and real estate, including your principal
                  residence, cash, short-term investments, stock and securities.
                  Equity in personal property and real estate should be based on
                  the appraised  fair market value of such  property,  less debt
                  secured by such property.

      _____ b. The undersigned is an individual (not a partnership, corporation,
            etc.) who had an income  in  excess of  $200,000  in each of the two
            most recent years,  or joint income with his or her spouse in excess
            of $300,000 in each of those years (in each case  including  foreign
            income,  tax exempt  income and the full amount of capital gains and
            losses,  but  excluding  any income of other family  members and any
            unrealized capital  appreciation),  and has a reasonable expectation
            of reaching the same income level in the current year.

      _____ c.    The  undersigned  is a  director  or  executive  officer  of
            Molecular Diagnostics, Inc. or a subsidiary thereof.

      _____ d. The undersigned is (i) a bank or a savings and loan  association,
            (ii) a registered broker dealer, (iii) an insurance company,  (iv) a
            registered investment company or business development company, (v) a
            licensed small business investment company,  (vi) a plan established
            and maintained by a state, its political subdivisions, or any agency
            or instrumentality of a state or its political  subdivisions (or any
            agency  or  instrumentality   thereof),   for  the  benefit  of  its
            employees,  if such plan has total  assets in excess of  $5,000,000,
            (vii) an  employee  benefit  plan  within the  meaning of Title I of
            ERISA, if the investment  decision is made by a plan fiduciary which
            is either a bank, savings and loan association, insurance company or
            registered  investment  adviser  or if the plan has total  assets in
            excess of  $5,000,000  or is a  self-directed  plan with  investment
            decisions made solely by persons that are accredited investors.

            Describe entity.

            --------------------------------------------------------

            --------------------------------------------------------

<PAGE>

      _____ e. The  undersigned  is a private  business  development  company as
            defined in Section  202(a)(22)  of the  Investment  Advisers  Act of
            1940, as amended.

            Describe entity.

            ---------------------------------------------------------

            ---------------------------------------------------------

      _____ f. The undersigned is a corporation,  partnership, business trust or
            non-profit  organization  within the meaning of Section 501(c)(3) of
            the Internal  Revenue Code, as amended,  in each case not formed for
            the  specific  purpose  of  potentially   making  an  investment  in
            connection herewith and with total assets in excess of $5,000,000.

            Describe entity.

            ----------------------------------------------------------

            ----------------------------------------------------------

      _____ g. The  undersigned is a trust (not formed for the specific  purpose
            of  potentially  making an investment in connection  herewith)  with
            total assets in excess of $5,000,000, where the purchase is directed
            by a person with the  knowledge  and  experience  in  financial  and
            business  matters  to capably  evaluate  the merits and risks of the
            prospective   investment,   as  set  forth  in  Rule   506(b)(2)(ii)
            promulgated under the Securities Act of 1933, as amended.

      _____ h. The  undersigned  is an entity all the equity owners of which are
            "accredited investors" within one or more of the above categories.

            Describe entity.

            ----------------------------------------------------------

            ----------------------------------------------------------

                                       8
<PAGE>

      The   undersigned   is  aware  of  the   significance   of  the  foregoing
representations.  The  undersigned is also aware that the above  representations
made by him,  her or it will be relied upon in  connection  with any  investment
made in Molecular  Diagnostics,  Inc.  pursuant to the accompanying  document or
documents.

Date:
       -----------------            ------------------------------------------
                                    Signature

                                    ------------------------------------------
                                    Print name

                                    Address:
                                              --------------------------------

                                    ------------------------------------------

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00102-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00102-of-00352.parquet"}]]